Financhill
Sell
17

NPSKY Quote, Financials, Valuation and Earnings

Last price:
$8.07
Seasonality move :
-2.12%
Day range:
$8.07 - $8.07
52-week range:
$8.07 - $11.84
Dividend yield:
5.19%
P/E ratio:
26.02x
P/S ratio:
0.37x
P/B ratio:
0.44x
Volume:
258
Avg. volume:
635
1-year change:
-22.21%
Market cap:
$2B
Revenue:
$5.5B
EPS (TTM):
$0.31
Period Ending 2020-03-31 2021-03-31 2022-03-31 2023-03-31 2024-03-31
Revenue $7.6B $7.1B $7.7B $5.8B $5.5B
Revenue Growth (YoY) -14.49% -7.77% 9.28% -25.36% -4.97%
 
Cost of Revenues $6.2B $5.9B $6.2B $4.5B $4.3B
Gross Profit $1.4B $1.2B $1.5B $1.3B $1.1B
Gross Profit Margin 18.47% 16.89% 19.62% 22.62% 20.95%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $1.2B $1.2B $1.3B $997M $976.6M
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $1.2B $1.2B $1.3B $1B $985.7M
Operating Income $196.2M $21.6M $228.4M $301M $159.5M
 
Net Interest Expenses -- $4.5M -- $4.1M $8.2M
EBT. Incl. Unusual Items $221.4M $55.6M $262.9M $320.5M $181.6M
Earnings of Discontinued Ops. -- -- -- -$69.3M -$32.5M
Income Tax Expense $54.8M $62.6M $105.6M $113M $82.8M
Net Income to Company $221.4M $55.6M $262.9M $236.4M $160.9M
 
Minority Interest in Earnings -$6.4M $10.4M -$9.6M -$1.8M -$7.4M
Net Income to Common Excl Extra Items $160.2M $3.3M $147.8M $136.4M $58.9M
 
Basic EPS (Cont. Ops) $0.63 $0.01 $0.58 $0.53 $0.24
Diluted EPS (Cont. Ops) $0.62 $0.01 $0.57 $0.53 $0.24
Weighted Average Basic Share $256.1M $256.2M $256.4M $256.5M $246.2M
Weighted Average Diluted Share $256.8M $257M $257.1M $257.4M $247.1M
 
EBITDA $744.7M $594.6M $785.8M $774M $590M
EBIT $248.5M $80.2M $282M $341.7M $215M
 
Revenue (Reported) $7.6B $7.1B $7.7B $5.8B $5.5B
Operating Income (Reported) $196.2M $21.6M $228.4M $301M $159.5M
Operating Income (Adjusted) $248.5M $80.2M $282M $341.7M $215M
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Revenue $1.2B $2B $1.4B $1.4B $1.3B
Revenue Growth (YoY) -40.96% 62.84% -27.4% -3.11% -6.25%
 
Cost of Revenues $1B $1.5B $1.1B $1.1B --
Gross Profit $157.2M $400.3M $320.5M $283.4M --
Gross Profit Margin 13.13% 20.53% 22.63% 20.66% --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $273.7M $326.8M $257.9M $260.9M --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $277.1M $328.1M $260.8M $258.6M --
Operating Income -$119.8M $72.2M $59.6M $24.9M $37.7M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$116.4M $85M $65.1M $31.2M $33.1M
Earnings of Discontinued Ops. -- -- -$21.3M -$18.1M --
Income Tax Expense -$24.3M $36.8M $29.7M $18.1M --
Net Income to Company -$116.4M $85M $34.9M $20.7M --
 
Minority Interest in Earnings $2M -$5.1M -$4M -$1.8M --
Net Income to Common Excl Extra Items -$90.1M $43M $10.2M -$6.8M $12.2M
 
Basic EPS (Cont. Ops) -$0.35 $0.17 $0.04 -$0.03 $0.05
Diluted EPS (Cont. Ops) -$0.35 $0.17 $0.04 -$0.03 $0.05
Weighted Average Basic Share $256.1M $256.4M $256.4M $250.5M $244.5M
Weighted Average Diluted Share $256.1M $257.2M $257.3M $251.6M $245.1M
 
EBITDA $13.8M $218.3M $180.5M $140.1M $37.7M
EBIT -$110.5M $89.7M $70.2M $38.3M $37.7M
 
Revenue (Reported) $1.2B $2B $1.4B $1.4B $1.3B
Operating Income (Reported) -$119.8M $72.2M $59.6M $24.9M $37.7M
Operating Income (Adjusted) -$110.5M $89.7M $70.2M $38.3M $37.7M
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Revenue $6.8B $7.8B $7.2B $5.7B $5.4B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $5.6B $6.4B $5.7B $4.4B --
Gross Profit $1.2B $1.4B $1.4B $1.3B --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $1.2B $1.2B $1.2B $1B --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $1.2B $1.2B $1.2B $997.5M --
Operating Income -$12.4M $216.2M $216.1M $265.8M $171.2M
 
Net Interest Expenses -- $5.2M $1.4M $3.6M $9.1M
EBT. Incl. Unusual Items $7.7M $259.6M $243.1M $286.3M $182.3M
Earnings of Discontinued Ops. -- -- -$21.3M -$66.8M -$15.3M
Income Tax Expense $18M $124.3M $98.5M $101.3M --
Net Income to Company $8.2M $257M $212.8M $222.3M --
 
Minority Interest in Earnings -$625.4K $3.3M -$8.6M $476.8K -$5.5M
Net Income to Common Excl Extra Items -$10.9M $138.6M $114.7M $118.7M $76.2M
 
Basic EPS (Cont. Ops) -$0.04 $0.54 $0.45 $0.46 $0.31
Diluted EPS (Cont. Ops) -$0.04 $0.54 $0.45 $0.46 $0.31
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $533.7M $801.7M $748.1M $733.2M $486.4M
EBIT $34.9M $283M $262.6M $309.5M $213.1M
 
Revenue (Reported) $6.8B $7.8B $7.2B $5.7B $5.4B
Operating Income (Reported) -$12.4M $216.2M $216.1M $265.8M $171.2M
Operating Income (Adjusted) $34.9M $283M $262.6M $309.5M $213.1M
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Revenue $1.2B $2B $1.4B $1.4B $1.3B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $1B $1.5B $1.1B $1.1B --
Gross Profit $157.2M $400.3M $320.5M $283.4M --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $273.7M $326.8M $257.9M $260.9M --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $277.1M $328.1M $260.8M $258.6M --
Operating Income -$119.8M $72.2M $59.6M $24.9M $37.7M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$116.4M $85M $65.1M $31.2M $33.1M
Earnings of Discontinued Ops. -- -- -$21.3M -$18.1M --
Income Tax Expense -$24.3M $36.8M $29.7M $18.1M --
Net Income to Company -$116.4M $85M $34.9M $20.7M --
 
Minority Interest in Earnings $2M -$5.1M -$4M -$1.8M --
Net Income to Common Excl Extra Items -$90.1M $43M $10.2M -$6.8M $12.2M
 
Basic EPS (Cont. Ops) -$0.35 $0.17 $0.04 -$0.03 $0.05
Diluted EPS (Cont. Ops) -$0.35 $0.17 $0.04 -$0.03 $0.05
Weighted Average Basic Share $256.1M $256.4M $256.4M $250.5M $244.5M
Weighted Average Diluted Share $256.1M $257.2M $257.3M $251.6M $245.1M
 
EBITDA $13.8M $218.3M $180.5M $140.1M $37.7M
EBIT -$110.5M $89.7M $70.2M $38.3M $37.7M
 
Revenue (Reported) $1.2B $2B $1.4B $1.4B $1.3B
Operating Income (Reported) -$119.8M $72.2M $59.6M $24.9M $37.7M
Operating Income (Adjusted) -$110.5M $89.7M $70.2M $38.3M $37.7M
Period Ending 2020-03-31 2021-03-31 2022-03-31 2023-03-31 2024-03-31
Cash and Equivalents $1.3B $1.6B $1.1B $1.2B $994.9M
Short Term Investments $29M $14.2M $13.6M $11.9M $297.8M
Accounts Receivable, Net $1.4B $1.7B $1.7B $1.6B $1.5B
Inventory $1.4B $1.4B $1.6B $1.5B $1.2B
Prepaid Expenses -- -- -- -- --
Other Current Assets $141.6M $143.7M $156.2M $140.8M $120.2M
Total Current Assets $4.3B $4.8B $4.7B $4.4B $4.2B
 
Property Plant And Equipment $3.6B $3.4B $3.1B $2.9B $2.4B
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles $182.9M $388.6M -- -- --
Other Long-Term Assets $57.3M $60.1M $45.9M $53.9M $43.1M
Total Assets $9.5B $10.6B $10.1B $9.3B $8.6B
 
Accounts Payable $899.3M $1B $982M $844.6M $928M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $419.2M $497.6M $465M $425.4M $347.4M
Total Current Liabilities $2B $2.7B $2.4B $2.3B $2.4B
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $4.7B $5.4B $4.9B $4.5B $4.1B
 
Common Stock $621.6M $609M $550.4M $504.2M $443.8M
Other Common Equity Adj -- -- -- -- --
Common Equity $4.7B $5B $5.1B $4.6B $4.4B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $194.4M $172.7M $161.1M $138.9M $118.8M
Total Equity $4.9B $5.2B $5.2B $4.8B $4.5B
 
Total Liabilities and Equity $9.5B $10.6B $10.1B $9.3B $8.6B
Cash and Short Terms $1.3B $1.6B $1.1B $1.2B $1.3B
Total Debt -- -- -- -- --
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $1.8B $1.2B $1.1B $1.2B $994.8M
Short Term Investments $16M $13.6M $12.3M $312.1M $166.6M
Accounts Receivable, Net $1.5B $1.6B $1.5B $1.5B $1.4B
Inventory $1.4B $1.6B $1.5B $1.2B $1.3B
Prepaid Expenses -- -- -- -- --
Other Current Assets $120.2M $142.1M $129.8M $121.4M $106.9M
Total Current Assets $4.8B $4.6B $4.3B $4.5B $4.1B
 
Property Plant And Equipment $3.5B $3.3B $2.7B $2.4B $2.4B
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles $177.5M $349.8M $326.4M -- --
Other Long-Term Assets $60.6M $80.6M $58.3M $42.5M $47.2M
Total Assets $10.2B $10.4B $8.8B $8.8B $8.5B
 
Accounts Payable $756.3M $911M $757.1M $955.2M $825.2M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $459.5M $468.7M $406.3M $333.2M $340M
Total Current Liabilities $2.4B $2.4B $2.1B $2.5B $2B
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $5.2B $5.1B $4.3B $4.4B $3.9B
 
Common Stock $635.7M $600.1M $465M $449.7M $470.4M
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $193.1M $168M $135.5M $116.4M $122M
Total Equity $5B $5.3B $4.5B $4.4B $4.6B
 
Total Liabilities and Equity $10.2B $10.4B $8.8B $8.8B $8.5B
Cash and Short Terms $1.8B $1.2B $1.1B $1.6B $1.2B
Total Debt -- -- -- -- --
Period Ending 2020-03-31 2021-03-31 2022-03-31 2023-03-31 2024-03-31
Net Income to Stockholders $221.4M $55.6M $262.9M $236.4M $160.9M
Depreciation & Amoritzation $496.2M $514.4M $503.8M $432.3M $375.1M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable $315.9M -$196.4M -$106M $37.8M $33.4M
Change in Inventories $5.3M $86.4M -$310.2M $46.9M $27.8M
Cash From Operations $666M $507.9M $202.5M $475.2M $691.7M
 
Capital Expenditures $440.5M $318.8M $370.8M $383.2M $406.8M
Cash Acquisitions -- -$189.8M -- -- -$75.7M
Cash From Investing -$366M -$482M -$177.9M -$361.2M -$629.3M
 
Dividends Paid (Ex Special Dividend) -$188.5M -$96.7M -$91.4M -$113.9M -$104.2M
Special Dividend Paid
Long-Term Debt Issued $438.8M $157.8M $80.2M $440M $593.7M
Long-Term Debt Repaid -$384.5M -$95.7M -$172M -$181M -$312.2M
Repurchase of Common Stock -$18.4K -$18.9K -$8.9K -$7.4K -$150.5M
Other Financing Activities $1.1M $3.7M $2.3M $2M $3.3M
Cash From Financing -$196.3M $282.9M -$429.6M $32.7M -$171.7M
 
Beginning Cash (CF) $1.2B $1.3B $1.6B $1B $1.1B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $103.7M $308.8M -$405M $146.6M -$109.3M
Ending Cash (CF) $1.3B $1.7B $1.2B $1.2B $1B
 
Levered Free Cash Flow $225.5M $189.1M -$168.3M $91.9M $285M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $15.9M $56.9M $57.9M $31.7M --
Depreciation & Amoritzation $129.5M $129.2M $99.6M $84.5M --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$239.2M $44.8M -$70.9M -$43.8M --
Change in Inventories $126.4M -$135.5M $49.7M $21.3M --
Cash From Operations $44M -$35.1M $24.9M $14.3M --
 
Capital Expenditures $95.7M $80.6M $88.1M $97.8M --
Cash Acquisitions -- -- -- -$75.6M --
Cash From Investing -$96.4M -$91.2M -$84.8M -$425.1M --
 
Dividends Paid (Ex Special Dividend) -$2M -$846K $1.9M $1.2M --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $1.3M -- $178.9M $557.3M --
Long-Term Debt Repaid -$1.6M -$960.2K $2.1M $4.5M --
Repurchase of Common Stock -- -- -- $7.9M --
Other Financing Activities $3.5M $2.3M $1.8M $2.8M --
Cash From Financing $71.3M -$83M $165.9M $436.9M --
 
Beginning Cash (CF) $1.7B $1.5B $1.1B $1.2B --
Foreign Exchange Rate Adjustment $1.6M -$2.5M $3.1M $3M --
Additions / Reductions $18.9M -$209.3M $106M $26.1M --
Ending Cash (CF) $1.8B $1.3B $1.2B $1.3B --
 
Levered Free Cash Flow -$51.7M -$115.7M -$63.1M -$83.5M --
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Net Income to Stockholders $8.2M $257M $212.8M $222.3M --
Depreciation & Amoritzation $498.8M $518.7M $485.5M $423.9M --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable $443.9M -$409.5M -$65.2M $70.4M --
Change in Inventories -$15.5M $29.6M -$263.7M $99.9M --
Cash From Operations $434.8M $538.8M $203.4M $852M --
 
Capital Expenditures $403.4M $285.5M $403M $408.6M $293.6M
Cash Acquisitions -- -- -- -- -$75.7M
Cash From Investing -$314.8M -$454.8M -$206.6M -$391.6M --
 
Dividends Paid (Ex Special Dividend) -$144.1M -$96.2M -$103.2M -$111M -$49.7M
Special Dividend Paid
Long-Term Debt Issued $529.2M $67.4M $114.2M $420.5M --
Long-Term Debt Repaid -$384M -$95M -$205.5M -$236.6M --
Repurchase of Common Stock -$18.4K -$18.9K -$8.9K -$158.3M --
Other Financing Activities -$103.5K $3.7M $2.3M $2M --
Cash From Financing $365.8M -$364.7M -$242.8M -$212.8M --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $485.7M -$280.7M -$246M $247.7M --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $31.4M $253.3M -$199.7M $443.5M --
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$100.5M $141.9M $92.8M $52.5M --
Depreciation & Amoritzation $253.8M $257.8M $209.9M $186.3M --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$17M $53.9M -$21M $38.7M --
Change in Inventories $69.7M -$249.1M -$17.4M $7.2M --
Cash From Operations $131.4M $83.2M $144.1M $510.3M --
 
Capital Expenditures $184.6M $136.1M $175.9M $211M --
Cash Acquisitions -- -- -- -$75.6M --
Cash From Investing -$178.2M -$145.9M -$168.1M -$538.8M --
 
Dividends Paid (Ex Special Dividend) -$48.3M -$46.6M -$55.7M -$53.3M --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $91.7M -- $212.9M $571.9M --
Long-Term Debt Repaid -$2.8M -$1.5M -$32M -$85.2M --
Repurchase of Common Stock -- -- -- -$150.3M --
Other Financing Activities $3.6M $2.4M $1.9M $2.8M --
Cash From Financing $511M -$290.9M $144.7M $170.3M --
 
Beginning Cash (CF) $3B $3.1B $2.2B $2.3B --
Foreign Exchange Rate Adjustment $7.9M $4.4M $37.4M $36.9M --
Additions / Reductions $464.2M -$353.6M $120.7M $141.8M --
Ending Cash (CF) $3.5B $2.7B $2.3B $2.5B --
 
Levered Free Cash Flow -$53.2M -$52.9M -$31.8M $299.4M --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock